2van Rhijin BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review [ J ] . Eur Urol, 2005, 47(6): 736-748. 被引量：1
3Soloway MS. Do we have a prostate specific antigen for bladder cancer [ J ]. J Urol, 1999, 161(2): 447-448. 被引量：1
4Bassi PF, Mostaccio G, Pappagallo GL, et al. BTA tests in the diagnosis and follow-up of superficial bladder cancer [ J ] . Arch Ital Urol Androl, 2003, 75(2): 105-109. 被引量：1
5Konety BR. Molecular markers in bladder cancer: a critical appraisal [ J ] . Urol Oncol, 2006, 24(4): 326-337. 被引量：1
6Boman H, Hedelin H, Holmang S. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence [ J ] . Urology, 2002, 167(1): 80-83. 被引量：1
7Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay [ J ] . JAMA, 2005, 293(7): 810-816. 被引量：1
8Grossman HB, Soloway M, Messing E, et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay [ J ]. JAMA, 2006, 295(3): 299-305. 被引量：1
9Southgate J, Harnden P, Trejdosiewicz LK. Cytokeratin expression patterns in normal and malignant urothelium: A review of the biological and diagnostic implications [ J ] . Histol Histopathol, 1999, 14(2): 657-664. 被引量：1
10Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, et al. A side by side comparison of cytology and biomarkers for bladder cancer detection [ J ]. J Urol, 2004, 172(3): 1123-1126. 被引量：1
